Immune Checkpoint Inhibitors for Cancer: A Primer on the Recognition and Management of Immune-Related Adverse Events
This interprofessional educational activity is designed to assist clinicians in managing immune-related adverse events (irAEs) that occur in patients with cancer being treated with immune checkpoint inhibitors.
CE Credits: 1.0-hour
In this podcast, expert faculty discuss the importance of timely identification and management of immune-related adverse events (irAEs) in patients being treated with immune-checkpoint inhibitors, including commonly asked questions.
Expert faculty reflect upon scenarios in their practice where they have seen the need for non-oncology specialists to be familiar with immune-related adverse events (irAEs), as well as strategies for overcoming challenges they have observed.